VEGFA and endometriosis: Risk of bias was frequently moderate to high, and therefore, small-study or publication bias cannot be excluded.<h4>Conclusion</h4>This study provides the first, exploratory comparative synthesis of VEGF-directed pharmacotherapies for endometriosis across pre-clinical and early-phase human models.